- Home
- FULTP vs GALT Comparison
FULTP vs GALT Comparison
Compare FULTP & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
FULTP
Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Current Price
Company Overview
Basic Information| Metric | FULTP | GALT |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | United States |
| Employees | 3400 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 232.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FULTP | GALT |
|---|---|---|
| Price | $19.30 | $4.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | N/A | ★ 714.1K |
| Earning Date | N/A | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | $0.73 |
| 52 Week High | N/A | $7.13 |
Technical Indicators
Market Signals| Indicator | FULTP | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 46.97 | 36.24 |
| Support Level | $19.06 | $6.03 |
| Resistance Level | $19.43 | $7.13 |
| Average True Range (ATR) | 0.22 | 0.71 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 69.77 | 17.12 |
Price Performance
Historical ComparisonAbout FULTP Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.